Company intelligence / Profile preview
Akouos
Boston, Massachusetts, United Statesakouos.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
Akouos’s lead program, AK-OTOF, is an AAV-based gene therapy targeting sensorineural hearing loss caused by mutations in the otoferlin gene. The program is currently in Phase 2 clinical trials. Preclinical data have shown promise for restoring physiologic hearing following a single administration to the inner ear. Additional programs are at preclinical or discovery stages targeting other forms of genetic hearing loss and related indications such as Usher syndrome and acoustic neuroma.
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- Gene therapyAdeno-associated viral (AAV) vector-based gene therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Lonza – technology licensing for ancestral AAV platformMassachusetts Eye and Ear – technology licensing/collaborationAcademic collaborations with leading scientists in otology/gene delivery
Beyond the preview
Go deeper on Akouos.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Akouos.